Pitfalls in Oncogeriatrics
Abstract
:Simple Summary
Abstract
1. Introduction
2. The Landscape
- the organization of an international society (Société Internationale de Oncogeriatrie, or SIOG), with hundreds of members from throughout the world [3]. The society meets yearly and has been issuing the Journal of Geriatric Oncology since fourteen years.
- The formation of cooperative research groups dedicated to clinical research in geriatric oncology. The most successful model of these groups that has spawned around the word is the Cancer and Aging Research Group (CARG) that was founded by the late Arti Hurria, counts on members from throughout the world, and includes geriatricians, oncologists, nurses, and other professionals involved in elderly care [21].
3. Obstacles
3.1. Geriatrics Specialists
3.2. Oncology Specialists
3.3. Ageism
4. Conclusions
- The optimal treatment of older persons with cancer may involve a personalized plan of care obtained by the close cooperation of oncology and geriatrics professionals. This cooperation should extend to clinical research involving the aged.
- This cooperation has been implemented only occasionally in high-income countries and is all but absent in middle- and low-income countries.
- The implementation of this system is embattled by many factors that include the scarcity of manpower among the most important factors.
- The prejudice toward older people both at the level of professionals and society exerts a negative influence in the generalized spread of the oncogeriatric approach.
- An additional problem that is not acceptable to mention in mixed company, but certainly underlies the resentment of older and disabled individuals, is the burden these individuals represent to the society. This includes the burden of financial resources, the burden on health care facilities, and the burden on the caregiver. Nobody has a definite response to this bulging problem, but the solution cannot consist of denying care to the patients based on chronologic age or disability, nor can it consist of ignoring the issue. We believe that the cooperation of oncologists and geriatrics specialists may represent a necessary initial step to solve this issue. The cooperation may allow the team to present the definitive benefits, risks of each treatment approach, and allow the patients to choose the course of action most fitting the individual condition.
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
References
- Chapman, A.E.; Elias, R.; Plotkin, E.; Lowenstein, L.M.; Swartz, K. Models of Care in Geriatric Oncology. J. Clin. Oncol. 2021, 39, 2195–2204. [Google Scholar] [CrossRef] [PubMed]
- Dotan, E.; Walter, L.C.; Browner, I.S.; Clifton, K.; Cohen, H.J.; Extermann, M.; Gross, C.; Gupta, S.; Hollis, G.; Hubbard, J.; et al. NCCN Guidelines(R) Insights: Older Adult Oncology, Version 1.2021. J. Natl. Compr. Cancer Netw. 2021, 19, 1006–1019. [Google Scholar] [CrossRef] [PubMed]
- Dubianski, R.; Wildes, T.M.; Wildiers, H. SIOG guidelines- essential for good clinical practice in geriatric oncology. J. Geriatr. Oncol. 2019, 10, 196–198. [Google Scholar] [CrossRef]
- Kunkler, I.H.; Audisio, R.; Belkacemi, Y.; Betz, M.; Gore, E.; Hoffe, S.; Kirova, Y.; Koper, P.; Lagrange, J.L.; Markouizou, A.; et al. Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: The International Society of Geriatric Oncology (SIOG) task force. Ann. Oncol. 2014, 25, 2134–2146. [Google Scholar] [CrossRef]
- Mohile, S.G.; Dale, W.; Somerfield, M.R.; Schonberg, M.A.; Boyd, C.M.; Burhenn, P.S.; Canin, B.; Cohen, H.J.; Holmes, H.M.; Hopkins, J.O.; et al. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. J. Clin. Oncol. 2018, 36, 2326–2347. [Google Scholar] [CrossRef] [PubMed]
- Balducci, L.; Monfardini, S. The Development of Geriatric Oncology in France: An Outside View. Available online: https://ascopost.com/issues/october-10-2022/the-development-of-geriatric-oncology-in-france-an-outside-view/ (accessed on 3 March 2023).
- Soto-Perez-de-Celis, E.; de Glas, N.A.; Hsu, T.; Kanesvaran, R.; Steer, C.; Navarrete-Reyes, A.P.; Battisti, N.M.L.; Chavarri-Guerra, Y.; O’Donovan, A.; Avila-Funes, J.A.; et al. Global geriatric oncology: Achievements and challenges. J. Geriatr. Oncol. 2017, 8, 374–386. [Google Scholar] [CrossRef]
- Eid, A.; Hughes, C.; Karuturi, M.; Reyes, C.; Yorio, J.; Holmes, H. An interprofessionally developed geriatric oncology curriculum for hematology–oncology fellows. J. Geriatr. Oncol. 2015, 6, 165–173. [Google Scholar] [CrossRef]
- Hsu, T.; Soto-Perez-de-Celis, E.; Burhenn, P.S.; Korc-Grodzicki, B.; Wildes, T.M.; Kanesvaran, R.; Maggiore, R.J. Educating healthcare providers in geriatric oncology—A call to accelerate progress through identifying the gaps in knowledge. J. Geriatr. Oncol. 2020, 11, 1023–1027. [Google Scholar] [CrossRef]
- Dale, W.; Williams, G.R.; MacKenzie, A.R.; Soto-Perez-de-Celis, E.; Maggiore, R.J.; Merrill, J.K.; Katta, S.; Smith, K.T.; Klepin, H.D. How Is Geriatric Assessment Used in Clinical Practice for Older Adults with Cancer? A Survey of Cancer Providers by the American Society of Clinical Oncology. JCO Oncol. Pract. 2021, 17, 336–344. [Google Scholar] [CrossRef]
- Hurria, A.; Mohile, S.; Gajra, A.; Klepin, H.; Muss, H.; Chapman, A.; Feng, T.; Smith, D.; Sun, C.L.; De Glas, N.; et al. Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults with Cancer. J. Clin. Oncol. 2016, 34, 2366–2371. [Google Scholar] [CrossRef]
- Muss, H.B.; Polley, M.C.; Berry, D.A.; Liu, H.; Cirrincione, C.T.; Theodoulou, M.; Mauer, A.M.; Kornblith, A.B.; Partridge, A.H.; Dressler, L.G.; et al. Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial. J. Clin. Oncol. 2019, 37, 2338–2348. [Google Scholar] [CrossRef] [PubMed]
- Sedrak, M.S.; Gilmore, N.J.; Carroll, J.E.; Muss, H.B.; Cohen, H.J.; Dale, W. Measuring Biologic Resilience in Older Cancer Survivors. J. Clin. Oncol. 2021, 39, 2079–2089. [Google Scholar] [CrossRef] [PubMed]
- Coiffier, B.; Lepage, E.; Briere, J.; Herbrecht, R.; Tilly, H.; Bouabdallah, R.; Morel, P.; Van Den Neste, E.; Salles, G.; Gaulard, P.; et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N. Engl. J. Med. 2002, 346, 235–242. [Google Scholar] [CrossRef] [PubMed]
- Gridelli, C.; Morabito, A.; Cavanna, L.; Luciani, A.; Maione, P.; Bonanno, L.; Filipazzi, V.; Leo, S.; Cinieri, S.; Ciardiello, F.; et al. Cisplatin-Based First-Line Treatment of Elderly Patients with Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials. J. Clin. Oncol. 2018, 36, 2585–2592. [Google Scholar] [CrossRef]
- Gridelli, C.; Perrone, F.; Gallo, C.; Cigolari, S.; Rossi, A.; Piantedosi, F.; Barbera, S.; Ferrau, F.; Piazza, E.; Rosetti, F.; et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J. Natl. Cancer Inst. 2003, 95, 362–372. [Google Scholar] [CrossRef]
- Investigators, E. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group. J. Natl. Cancer Inst. 1999, 91, 66–72. [Google Scholar] [CrossRef]
- Palumbo, A.; Bringhen, S.; Mateos, M.V.; Larocca, A.; Facon, T.; Kumar, S.K.; Offidani, M.; McCarthy, P.; Evangelista, A.; Lonial, S.; et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: An International Myeloma Working Group report. Blood 2015, 125, 2068–2074. [Google Scholar] [CrossRef]
- Perrone, F.; Nuzzo, F.; Di Rella, F.; Gravina, A.; Iodice, G.; Labonia, V.; Landi, G.; Pacilio, C.; Rossi, E.; De Laurentiis, M.; et al. Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: Final results of the randomized phase III ELDA trial. Ann. Oncol. 2015, 26, 675–682. [Google Scholar] [CrossRef]
- Quoix, E.; Zalcman, G.; Oster, J.P.; Westeel, V.; Pichon, E.; Lavole, A.; Dauba, J.; Debieuvre, D.; Souquet, P.J.; Bigay-Game, L.; et al. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet 2011, 378, 1079–1088. [Google Scholar] [CrossRef]
- Rosko, A.E.; Steer, C.; Chien, L.C.; Zittel, J.; Artz, A.; Chow, S.; Plotkin, E.; Dale, W.; Elias, R.; Chapman, A.E. The Cancer and Aging Research Group (CARG) infrastructure: The clinical implementation core. J. Geriatr. Oncol. 2021, 12, 1164–1165. [Google Scholar] [CrossRef]
- Bensadon, B.A.; Teasdale, T.A.; Odenheimer, G.L. Attitude adjustment: Shaping medical students’ perceptions of older patients with a geriatrics curriculum. Acad. Med. 2013, 88, 1630–1634. [Google Scholar] [CrossRef] [PubMed]
- European Union of Medical Specialists(UEMS), Geriatric.Medicine(GM) (-S.o. Available online: https://www.uemsgeriatricmedicine.org/www/ (accessed on 16 March 2023).
- Barbagallo, M.; Dominguez, L.J. Gerontology is essential to the identity of geriatric medicine. Eur. Geriatr. Med. 2019, 10, 835–837. [Google Scholar] [CrossRef] [PubMed]
- Reiter, R.; Diraoui, S.; Van Den Noortgate, N.; Cruz-Jentoft, A.J. How to become a Geriatrician in different European countries. Eur. Geriatr. Med. 2014, 5, 347–351. [Google Scholar] [CrossRef]
- Fisher, J.M.; Masud, T.; Holm, E.A.; Roller-Wirnsberger, R.E.; Stuck, A.E.; Gordon, A.; Blain, H.; Knight, P.; Frühwald, T.; Petermans, J.; et al. New horizons in geriatric medicine education and training: The need for pan-European education and training standards. Eur. Geriatr. Med. 2017, 8, 467–473. [Google Scholar] [CrossRef]
- Mateos-Nozal, J.; Cruz-Jentoft, A.J.; Ribera Casado, J.M. A systematic review of surveys on undergraduate teaching of Geriatrics in medical schools in the XXI century. Eur. Geriatr. Med. 2014, 5, 119–124. [Google Scholar] [CrossRef]
- Morley, J.E. Editorial: The Future of Geriatrics. J. Nutr. Health Aging 2020, 24, 1–2. [Google Scholar] [CrossRef]
- Le Couteur, D.G.; Flicker, L.; Hilmer, S.N. Geriatric medicine and health care for older people in Australia. Age Ageing 2022, 51, afac001. [Google Scholar] [CrossRef]
- Guimaraes, R.M. Ageing in developing countries. In Pathy’s Principles and Practice of Geriatric Medicine, 5th ed.; Alan, J., Sinclair, J.E.M., Vellas, B., Eds.; Wiley-Blackwell: Hoboken, NJ, USA, 2012. [Google Scholar]
- Emanuel, E.J. Why I Hope to Die at 75. Available online: https://www.theatlantic.com/magazine/archive/2014/10/why-i-hope-to-die-at-75/379329/ (accessed on 20 April 2023).
- Kanesvaran, R.; Mohile, S.; Soto-Perez-de-Celis, E.; Singh, H. The Globalization of Geriatric Oncology: From Data to Practice. Am. Soc. Clin. Oncol. Educ. Book 2020, 40, e107–e115. [Google Scholar] [CrossRef]
- Sifer-Riviere, L.; Saint-Jean, O.; Gisselbrecht, M.; Cudennec, T.; Girre, V.; Programme d’OncoGeriatrie de l’Ouest, P. What the specific tools of geriatrics and oncology can tell us about the role and status of geriatricians in a pilot geriatric oncology program. Ann. Oncol. 2011, 22, 2325–2329. [Google Scholar] [CrossRef]
- Hortobagyi, G.N.; American Society of Clinical Oncology. A shortage of oncologists? The American Society of Clinical Oncology workforce study. J. Clin. Oncol. 2007, 25, 1468–1469. [Google Scholar] [CrossRef]
- Kirkwood, M.K.; Hanley, A.; Bruinooge, S.S.; Garrett-Mayer, E.; Levit, L.A.; Schenkel, C.; Seid, J.E.; Polite, B.N.; Schilsky, R.L. The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey. J. Oncol. Pract. 2018, 14, e412–e420. [Google Scholar] [CrossRef] [PubMed]
- Holmes, H.M.; Albrand, G. Organizing the geriatrician/oncologist partnership: One size fits all? Practical solutions. Interdiscip. Top. Gerontol. 2013, 38, 132–138. [Google Scholar] [CrossRef] [PubMed]
- Bhinder, B.; Gilvary, C.; Madhukar, N.S.; Elemento, O. Artificial Intelligence in Cancer Research and Precision Medicine. Cancer Discov. 2021, 11, 900–915. [Google Scholar] [CrossRef] [PubMed]
- Dittrich, C.; Kosty, M.; Jezdic, S.; Pyle, D.; Berardi, R.; Bergh, J.; El-Saghir, N.; Lotz, J.P.; Osterlund, P.; Pavlidis, N.; et al. ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open 2016, 1, e000097. [Google Scholar] [CrossRef]
- Kumar, A.; Soares, H.P.; Balducci, L.; Djulbegovic, B.; National Cancer Institute. Treatment tolerance and efficacy in geriatric oncology: A systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groups. J. Clin. Oncol. 2007, 25, 1272–1276. [Google Scholar] [CrossRef] [PubMed]
- Lichtman, S.M. Geriatricizing clinical trials: The legacy of Arti Hurria, MD. J. Geriatr. Oncol. 2020, 11, 149–150. [Google Scholar] [CrossRef]
- Talarico, L.; Chen, G.; Pazdur, R. Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US Food and Drug Administration. J. Clin. Oncol. 2004, 22, 4626–4631. [Google Scholar] [CrossRef]
- Hamaker, M.E.; Wildes, T.M.; Rostoft, S. Time to Stop Saying Geriatric Assessment Is Too Time Consuming. J. Clin. Oncol. 2017, 35, 2871–2874. [Google Scholar] [CrossRef]
- Zietlow, K.E.; Wong, S.P. Social and community aspects of ageing. In Pathy’s Principles and Practice of Geriatric Medicine; John Wiley & Sons: Hoboken, NJ, USA, 2022; pp. 43–58. [Google Scholar]
Special geriatric oncology units |
|
Professional education through major professional association |
|
Geriatric module as part of the training in hematology oncology |
|
Double clinical training in oncology and geriatrics |
|
Dedicated clinical trials in the elderly in major oncology group |
|
Manpower scarcity and distribution |
Professional interest in aging |
Ageism |
Geriatrician’s tools and know-how, often perceived ambiguously |
Oncologists unclear as to the Geriatricians role |
Lack of Governmental initiatives to promote studies of cancer in the elderly |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Monfardini, S.; Perrone, F.; Balducci, L. Pitfalls in Oncogeriatrics. Cancers 2023, 15, 2910. https://doi.org/10.3390/cancers15112910
Monfardini S, Perrone F, Balducci L. Pitfalls in Oncogeriatrics. Cancers. 2023; 15(11):2910. https://doi.org/10.3390/cancers15112910
Chicago/Turabian StyleMonfardini, Silvio, Francesco Perrone, and Lodovico Balducci. 2023. "Pitfalls in Oncogeriatrics" Cancers 15, no. 11: 2910. https://doi.org/10.3390/cancers15112910